[Systematic review and Meta-analysis of safety of Sanfu acupoint herbal patching in randomized controlled trial].

传统医学 医学 随机对照试验 荟萃分析 针灸科 替代医学 内科学 病理
标识
DOI:10.19540/j.cnki.cjcmm.20200730.501
摘要

In order to systematically evaluate the safety of Sanfu acupoint herbal patching, CNKI, SinoMed, VIP, Wanfang, PubMed, Medline, EMbase, and Cochrane Library were searched in accordance with PICOS principles, with a time limit from database establishment to December 2019. Meta-analysis was used for a single-group rate analysis and a weighted combination of these two groups on rates of adverse reactions. A total of 9 articles meeting the inclusion criteria were included in the analysis, involving 2 119 patients. The single-group rate Meta-analysis showed that the adverse reactions incidence was 9% in the treatment group(OR=0.10,95%CI[0.06, 0.19], P<0.000 01), and 9% in the control group(OR=0.10, 95%CI[0.07, 0.13], P<0.000 01). In combined statistics of all samples OR=1.81, 95%CI[1.04, 3.15], P=0.04, the incidence of adverse reactions in the treatment group was slightly higher than that of the control group. In the subgroup analysis, the incidence of adverse reactions in terms of both single-group rate and weighed rate in the treatment group was higher than that in the control group in the asthma subgroup, rhinitis subgroup, ≥18 years old subgroup, and application time 2 h subgroup, with statistically significant differences(P<0.05). The results of the Meta-analysis and systematic review suggested that the incidence of adverse reactions in clinical use of the Sanfu acupoints herbal patching was relatively low. The main types of adverse reactions were skin ulcers, blisters and other skin symptoms. The symptoms were relatively mild, which could be relieved by drug withdrawal or symptomatic treatment. It shows that the safety of the Sanfu acupoint herbal patching was relatively high, and the occurrence of adverse reactions was related to the original disease and age, mainly in asthma and rhinitis or patients over 40 years old. Affected by clinical heterogeneity, the conclusions of the application time subgroup need to be further improved.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
会发光的喷火龙完成签到,获得积分10
刚刚
刚刚
刚刚
婉君完成签到,获得积分20
刚刚
卡瓦格博发布了新的文献求助10
1秒前
日月完成签到 ,获得积分10
1秒前
2秒前
GALN完成签到 ,获得积分10
2秒前
李健应助123采纳,获得10
2秒前
2秒前
小红应助超级灵寒采纳,获得10
3秒前
3秒前
加贝峥发布了新的文献求助10
3秒前
完美连虎发布了新的文献求助30
4秒前
思源应助科研通管家采纳,获得10
4秒前
栀子完成签到,获得积分10
4秒前
CodeCraft应助科研通管家采纳,获得10
4秒前
4秒前
香蕉觅云应助科研通管家采纳,获得10
4秒前
infe完成签到,获得积分10
4秒前
mengtingmei应助科研通管家采纳,获得20
4秒前
田様应助科研通管家采纳,获得10
4秒前
4秒前
Jasper应助科研通管家采纳,获得10
4秒前
4秒前
小二郎应助科研通管家采纳,获得10
5秒前
5秒前
李爱国应助科研通管家采纳,获得10
5秒前
英俊的铭应助科研通管家采纳,获得10
5秒前
流云发布了新的文献求助10
5秒前
bkagyin应助科研通管家采纳,获得10
5秒前
WIFI123发布了新的文献求助10
5秒前
华仔应助科研通管家采纳,获得10
5秒前
5秒前
Orange应助科研通管家采纳,获得10
5秒前
丘比特应助科研通管家采纳,获得10
5秒前
乐乐应助科研通管家采纳,获得10
5秒前
SciGPT应助科研通管家采纳,获得10
5秒前
彭于晏应助科研通管家采纳,获得10
5秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Organometallic Chemistry of the Transition Metals 800
Chemistry and Physics of Carbon Volume 18 800
The Organometallic Chemistry of the Transition Metals 800
The formation of Australian attitudes towards China, 1918-1941 640
Signals, Systems, and Signal Processing 610
全相对论原子结构与含时波包动力学的理论研究--清华大学 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6438853
求助须知:如何正确求助?哪些是违规求助? 8253035
关于积分的说明 17563855
捐赠科研通 5497124
什么是DOI,文献DOI怎么找? 2899149
邀请新用户注册赠送积分活动 1875767
关于科研通互助平台的介绍 1716511